Quick Takeaways
- 3i, LP filed SCHEDULE 13G for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX).
- Disclosed ownership: 9.9%.
- Date of event: 05 Feb 2025.
3i, LP - 05 Feb 2025 SCHEDULE 13G Report for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX)
- Filing Manager
- 3i, LP
- Reporting Manager
- 3i, LP
- Symbol
- BCTX
- Shares outstanding
- 3,727,273 shares
- Disclosed Ownership
- 369,000 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Feb 2025, 21:02:32 UTC
- Date of event
- 05 Feb 2025
- Next filing
- 13 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"3i, LP disclosed 9.9% ownership in BriaCell Therapeutics Corp. Common Shares, no par value (BCTX) on 05 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 21:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 3i, LP | 9.9% | 369,000 | 0 | 369,000 | /s/ 3i, LP | Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP | |
| 3i Management LLC | 9.9% | 369,000 | 0 | 369,000 | /s/ 3i Management LLC | Maier Joshua Tarlow, Manager | |
| Maier Joshua Tarlow | 9.9% | 369,000 | 0 | 369,000 | /s/ Maier Joshua Tarlow | Maier Joshua Tarlow |